Twin City Private Wealth’s GSK GSK Stock Holding History

Twin City Private Wealth’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.4M	Buy	45,434 +989	+2%	+$52.3K	1.68%	18
2026 Q1	$2.47M	Buy	44,445 +533	+1%	+$28.9K	1.88%	18
2025 Q4	$2.17M	Sell	43,912 -153	-0.3%	-$7.14K	1.64%	23
2025 Q3	$1.92M	Buy	44,065 +1,318	+3%	+$51.5K	1.5%	25
2025 Q2	$1.66M	Buy	42,747 +1,266	+3%	+$48.4K	1.36%	26
2025 Q1	$1.63M	Sell	41,481 -4,279	-9%	-$157K	1.43%	26
2024 Q4	$1.56M	Buy	45,760 +5,417	+13%	+$195K	1.38%	27
2024 Q3	$1.67M	Sell	40,343 -849	-2%	-$34.7K	1.44%	30
2024 Q2	$1.6M	Buy	41,192 +909	+2%	+$38.2K	1.51%	27
2024 Q1	$1.74M	Buy	+40,283	New	+$1.66M	1.72%	22

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Twin City Private Wealth's GSK Position: Q2 2026 in Review

Twin City Private Wealth increased its GSK (GSK) stake by 2.2% in Q2 2026, buying an estimated $52.3K and bringing the position to 45,434 shares worth $2.4M. The position accounts for 1.68% of the portfolio, ranked #18.

Twin City Private Wealth first reported a position in GSK in Q1 2024 and has held it in 10 quarters since. The position peaked at $2.47M in Q1 2026. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Twin City Private Wealth held 45,434 shares of GSK worth $2.4M as of Q2 2026.
Twin City Private Wealth bought 989 GSK shares in Q2 2026, an estimated $52.3K.
GSK made up 1.68% of Twin City Private Wealth's portfolio in Q2 2026, its #18 holding.
Twin City Private Wealth first reported a position in GSK in Q1 2024 and has held it in 10 quarters since.
Twin City Private Wealth's GSK position peaked at $2.47M in Q1 2026.
1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Twin City Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.